LICENSE AGREEMENTLicense Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledMarch 12th, 2008 Company Industry JurisdictionThis Exclusive License Agreement (this “Agreement”) is entered into on January 4, 2008 (the “Effective Date”) between BioMimetic Therapeutics, Inc. (“BMTI”), a Delaware corporation, and Luitpold Pharmaceuticals, Inc. (“Luitpold”), a New York corporation (each, individually, a “Party” and, collectively, the “Parties”).
AGREEMENT TERMINATING MANUFACTURING AND SUPPLY AGREEMENTTermination Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledMarch 12th, 2008 Company Industry JurisdictionTHIS AGREEMENT TERMINATING MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), is entered into as of January 4, 2008, between BioMimetic Therapeutics, Inc., a Delaware corporation (f/k/a BioMimetic Pharmaceuticals, Inc.) (“BMTI”), and Luitpold Pharmaceuticals, Inc., a New York corporation (“Luitpold”). BMTI and Luitpold are each a “party” and are together, the “parties” to this Agreement.
EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Tennessee
Contract Type FiledMarch 12th, 2008 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (“Agreement”) made effective as of January 1, 2008 by and between BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), and Dr. Samuel E. Lynch (the “Executive”).
AGREEMENT TERMINATING RESEARCH, DEVELOPMENT AND MARKETING AGREEMENTTermination Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledMarch 12th, 2008 Company Industry JurisdictionThis AGREEMENT TERMINATING RESEARCH, DEVELOPMENT AND MARKETING AGREEMENT (this “Agreement”), is entered into as of January 4, 2008, between BioMimetic Therapeutics, Inc., a Delaware corporation (f/k/a BioMimetic Pharmaceuticals, Inc.) (“BMTI”), and Luitpold Pharmaceuticals, Inc., a New York corporation (“Luitpold”).
AMENDMENT AND WAIVER AGREEMENT with respect to ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledMarch 12th, 2008 Company IndustryTHIS AMENDMENT AND WAIVER AGREEMENT WITH RESPECT TO ASSET PURCHASE AGREEMENT (this “Amendment”) is entered into and effective as of January 4, 2008, between BioMimetic Therapeutics, Inc., a Delaware corporation (“Seller”), and Luitpold Pharmaceuticals, Inc., a New York corporation (“Buyer”).
AMENDED AND RESTATED EXCLUSIVE SUBLICENSE AGREEMENTExclusive Sublicense Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledMarch 12th, 2008 Company Industry JurisdictionThis Amended and Restated Exclusive Sublicense Agreement (“Agreement”) is entered into on January 4, 2008 (“Effective Date”) between BioMimetic Therapeutics, Inc. (“BMTI”), a Delaware corporation (formerly known as BioMimetic Pharmaceuticals, Inc.) and Luitpold Pharmaceuticals, Inc. (“Luitpold”), a New York corporation (each, individually, a “Party” and, collectively, the “Parties”).
ASSET PURCHASE AGREEMENT between BIOMIMETIC THERAPEUTICS, INC. and LUITPOLD PHARMACEUTICALS, INC. Dated as of December 14, 2007Asset Purchase Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledMarch 12th, 2008 Company Industry JurisdictionASSET PURCHASE AGREEMENT, dated as of December 14, 2007, between BioMimetic Therapeutics, Inc., a Delaware corporation (“Seller”), and Luitpold Pharmaceuticals, Inc., a New York corporation (“Buyer”).
SUPPLY AGREEMENTSupply Agreement • March 12th, 2008 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledMarch 12th, 2008 Company Industry JurisdictionThis Supply Agreement (this “Agreement”), effective as of January 4, 2008 (the “Effective Date”), is made by and between BioMimetic Therapeutics, Inc., a Delaware corporation with offices at 389-A Nichol Mill Lane, Franklin, TN 37067 (“BMTI”), and Luitpold Pharmaceuticals, Inc., a New York corporation with offices at One Luitpold Drive, P.O. Box 9001, Shirley, NY 11967 (“Luitpold”).